News
Support from the Cancera foundation for ovarian cancer research
Doctor Anna Sandström Gerdtsson has received 2 million SEK from the Cancera foundation for Spatial analysis of immune infiltration for individualized treatment of ovarian cancer. The study, which will be one of the first projects of the recently established SpatialOmics@LU facility, will generate a multiplex depiction of the immune environment [...]
Researcher at the Department of Immunotechnology presents on the clinical utility of protein modifications (PTMs) at the inaugural Chaperone Code Symposium
Doctor Magnus Jakobsson will present his work 28.10.2020 on the enzymology and clinical relevance of post‑translational modifications (PTM) of the universally conserved protein Hsp70. His work has uncovered the human enzyme METTL21A (Uniprotein ID: Q8WXB1) as a specific methyltransferase targeting Lys561 in Hsp70 and demonstrated the value of this [...]
Kathrin Zeller appointed as Associate Professor in Immunotechnology
Doctor Kathrin Zeller was 28.8.2020 appointed as Associate Professor in Immunotechnology by the Faculty of Engineering at Lund University. Her research focuses on in vitro models to investigate human cellular toxicity caused by various stresses, such as chemicals, chemical mixtures and nanoparticles. Currently, her team evaluates the capacity [...]
CanFaster Ph.D. student represents cancer research at the EU exhibition Science is Wonderful!
Aastha Sobti, one of the CanFaster Ph.D. students at the Department of Immunotechnology, represents cancer research at the EU online exhibition Science is Wonderful! Her work on tonsil cancer was selected as one of the forty best research projects with EU funding all around the world. The exhibition is part of the European Research and [...]
Department of Immunotechnology researcher defines criteria that establishes lab-derived antibodies as opposed to animal-derived antibodies as the preferred option in reproducible, high quality science
Professor Carl Borrebaeck of the Department of Immunotechnology and CREATE Health, a Strategic Center for Translational Cancer Research, has, as an expert scientist member of the EU Reference Laboratory for Alternatives to Animal Testing reviewed the scientific validity of non-animal-derived antibodies and non antibody affinity reagents used for [...]
Support from the Crafoord foundation to PTM research
Magnus Jakobsson has received a 400 k SEK research grant from the Crafoord Foundation to develop new mass spectrometry-based methods for the analysis of protein post-translational modifications.
Wallenberg Foundation and SciLifeLab supports antibody research
A research team headed by Prof. Mats Ohlin of the Dept. of Immunotechnology has received funding for studies and development of human antibodies specific for the SARS-CoV-2 virus, the virus that cause COVID-19. The collaborative team includes researchers at Lund University, Skåne University Hospital, the Karolinska Institute, and the Royal [...]
Anne Ljungars defends thesis in Immunotechnology
Antibody technology and phenotypic discovery
Kristina Lundberg appointed as Associate Professor in Immunotechnology (copy 1)
Dr. Kristina Lundberg was today appointed as Associate Professor in Immunotechnology by the Faculty of Engineering at Lund University. Her research is focused on how to trigger the body’s own immune system to fight cancer. Currently, the team is performing studies on bladder cancer and acute myeloid leukemia. Based on analysis of immune cells [...]
Poster prize in experimental immunology awarded to researcher at the Dept. of Immunotechnology
Linnea Thörnqvist of the Department of Immunotechnology was recently awarded a prize for best poster in experimental immunology at the 3rd international meeting on Stochasticity and Control in Immune Repertoire, in Haifa, Israel. The poster covered a current study on so-called public antibodies associated with allergic response to the timothy grass [...]